SynCardia Systems backs out of its nearly $28M IPO
It appears SynCardia still has some kinks to work out - IPO on its artificial heart maker device is put on hold.
It appears SynCardia still has some kinks to work out - IPO on its artificial heart maker device is put on hold.
To keep up with the demand for its total artificial heart, Tucson-based Syncardia is in the midst of a Series F funding round, a spokesman said. This isn’t new technology. The company’s had Food and Drug Administration approval for the device for just about a decade; however, Syncardia says it’s the only approved total artificial heart […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
An artificial heart maker in Tucson, Ariz., has raised $14 million to go small with its temporary Total Artificial Heart. Syncardia wants to build a 50cc version of the device. SWK Holdings Corporation contributed $10 million to this round. SWK is a publicly traded, specialized finance company with a focus on the global healthcare sector. […]